Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.7%

14 terminated/withdrawn out of 819 trials

Success Rate

92.8%

+6.3% vs industry average

Late-Stage Pipeline

10%

81 trials in Phase 3/4

Results Transparency

3%

5 of 180 completed trials have results

Key Signals

200 recruiting5 with results6 terminated8 withdrawn

Enrollment Performance

Analytics

N/A
242(43.8%)
Phase 2
125(22.6%)
Phase 1
98(17.7%)
Phase 3
49(8.9%)
Phase 4
32(5.8%)
Early Phase 1
7(1.3%)
553Total
N/A(242)
Phase 2(125)
Phase 1(98)
Phase 3(49)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (819)

Showing 20 of 819 trials
NCT05545293Completed

Prospective Study on Double-Stapling End-to-End Gastroduodenostomy Billroth-I Anastomosis in Laparoscopy-Assisted Surgery for Locally Advanced Distal Gastric Cancers

Role: lead

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07602868Not Yet Recruiting

A Comparative Study of Delayed Endoscopic DTI and Autologous Flap Reconstruction Post-Mastectomy

Role: lead

NCT07636798Phase 1Recruiting

Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer

Role: lead

NCT07612774Phase 4Recruiting

CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS

Role: lead

NCT07635823Not ApplicableRecruiting

Adaptive DBS for PD RCT

Role: collaborator

NCT07635277Phase 1Recruiting

Akkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury

Role: lead

NCT07567222Phase 1Recruiting

Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors

Role: lead

NCT07253389Not ApplicableRecruiting

Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis

Role: collaborator

NCT07635290Phase 2Active Not Recruiting

Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

Role: lead

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07625423Phase 1Recruiting

Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors

Role: lead

NCT07622212Recruiting

Comparison Of Different Mechanical Thrombectomy Devices in Endovascular Treatment of Acute Iliofemoral Venous Thrombosis

Role: collaborator

NCT07622199Not ApplicableNot Yet Recruiting

PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis

Role: collaborator

NCT05322330Phase 2Completed

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Role: collaborator

NCT07616323Not Yet Recruiting

Screening LUMBAR Syndrome in Infants With Infantile Hemangiomas

Role: lead

NCT02688036Phase 3Completed

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC

Role: collaborator

NCT07610707Phase 1Not Yet Recruiting

YMN-A02 for Advanced pMMR Colorectal Cancer With Liver Metastases

Role: lead

NCT06773130Phase 1Active Not Recruiting

HRS-4642 Combined With Nimotuzumab in the Treatment of Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma

Role: lead

NCT07538479Phase 1Recruiting

Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)

Role: lead